Latest News about BLUE
Recent news which mentions BLUE
Bluebird's Gene Therapy Scores US Approval For Genetic Blood Disorder, Probably The Most Expensive
August 17, 2022
Tickers
BLUE
From Benzinga
From Motley Fool
From Benzinga
Analysts See Softened Timelines For CRISPR Therapeutics' Sickle Cell Candidate In US
August 09, 2022
From Benzinga
Why Verona Pharma Is Trading Higher By Around 84%, Here Are 85 Stocks Moving In Tuesday's Mid-Day Session
August 09, 2022
From Benzinga
Why Is BIMI International Medical Higher By Around 70%: Here Are 38 Stocks Moving Premarket
August 09, 2022
From Benzinga
From Benzinga
Thomas J. Klima has been named Chief Commercial and Operating Officer of bluebird bio (BLUE). BLUE is trading at $4.71
August 07, 2022
Tickers
BLUE
From Best Stocks
Benzinga's Top Ratings Upgrades, Downgrades For August 2, 2022
August 02, 2022
From Benzinga
Where Will CRISPR Therapeutics Be in 1 Year?
July 31, 2022
From Motley Fool
From Benzinga
Why Legend Biotech's Shares Jumped 11.8% on Wednesday
July 27, 2022
From Motley Fool
Down 35% This Year, Is This Small-Cap Stock a Buy?
July 21, 2022
From Motley Fool
7 Biotech Stocks to Buy for Q3
July 18, 2022
From InvestorPlace
From Benzinga
This Company Could Ease the Pain in a Bear Market
July 09, 2022
From Motley Fool
From Motley Fool
7 Oversold Stocks to Buy in July 2022
July 06, 2022
From InvestorPlace
From Benzinga
From Benzinga
2 Biotech Stocks That Could Soar in the Third Quarter
July 02, 2022
From Motley Fool
From Benzinga
From Benzinga
From Benzinga
7 Oversold Stocks on the Verge of Blasting Off
June 22, 2022
From InvestorPlace
89 Biggest Movers From Friday
June 21, 2022
From Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.